VANCOUVER, British Columbia--(BUSINESS WIRE)--May 23, 2006--Bayer HealthCare Pharmaceuticals (Bayer) announced today it is awarding $2.75 million in grant money through the Bayer Hemophilia Awards Program (BHAP). The funding will support 25 cutting-edge research and education projects in hemophilia and related bleeding disorders. Bayer honored the 26 recipients during a special awards dinner and ceremony in conjunction with the 2006 WFH World Congress in Vancouver.
